Objective  To investigate the clinical efficacy of batroxobin (BX) combined with ginaton injection solution(GIS) in patients with sudden deafness with vertigo (SDV).

Methods  SDV patients admitted to Yan'an City People's Hospital from April 2020 to January 2023 were retrospectively selected as study subjects, and were divided into the BX group (dexamethasone combined with BX) and the GIS group (dexamethasone combined with BX and GIS) based on the different treatment programs of the patients. The clinical efficacy, hearing recovery time, tinnitus relief time and vertigo relief time of the two groups were compared. The occurrence of adverse reactions during treatment were observed and compared. The levels of serum inflammatory factors [tumor necrosis factor-α (TNF-α), hypersensitive C-reactive protein (Hs-CRP), interleukin-6 (IL-6)] before and after treatment in the two groups were compared.

Results  A total of 90 patients with SDV were included in the study, 49 and 41 in the GIS and BX groups, respectively. The total effective rate of treatment in the GIS group was significantly higher than that in the BX group (P<0.05). The time for hearing restoration, when tinnitus was relieved, and the time for vertigo to be relieved in the GIS group was significantly shorter than that in the BX group (P<0.05). The total effective rate of treatment in the GIS group was significantly higher than that in the BX group (P<0.05). Before treatment, the differences in serum TNF-α, Hs-CRP and IL-6 between the two groups were not statistically significant (P>0.05); after treatment, the levels of serum TNF-α, Hs-CRP and IL-6 in the two groups were significantly lower than those before treatment (P<0.05); and the levels in the GIS group were lower than those in the BX group (P<0.05). The difference in the incidence of adverse reactions between the two groups was not statistically significant (P>0.05).

Conclusion   The efficacy of GIS combined with BX in the treatment of SDV patients is remarkable, which can shorten the time of hearing recovery, tinnitus relief and vertigo relief of the patients, which may be related to the reduction of the level of inflammation in the body by GIS and BX.

1.金开林, 赵琴, 黄应亮. 鼓室注射糖皮质激素和高压氧治疗对特发性突发性感音神经性耳聋的疗效 [J].  中国药师, 2024, 27(2): 302-308. [Jin KL, Zhao Q, Huang YL. The therapeutic effect of tympanic injection of glucocorticoids and hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss[J]. Chinese Pharmacist, 2024, 27(2): 302-308.] DOI: 10.12173/j.issn.1008-049X.202312105.

2.胡潇红, 宁荣霞. 突发性耳聋的发病机制与治疗康复现状[J]. 中国康复, 2020, 35(9): 496-500. [Hu XH, Ning RX. The pathogenesis and treatment of sudden deafness[J]. Chinese Journal of Rehabilitation, 2020, 35(9): 496-500.] DOI: 10.3870/zgkf.2020.09.012.

3.余津颖, 陈飞云, 赵欢娣, 等. 突发性聋伴眩晕患者头脉冲抑制试验特征分析[J]. 听力学及言语疾病杂志, 2021, 29(4): 434-437. [Yu JY, Chen FY, Zhao HD, et al. Characteristics analysis of head pulse suppression test in patients with sudden deafness and dizziness[J]. Journal of Audiology and Speech Disorders, 2021, 29(4): 434-437.] DOI: 10.3969/j.issn.1006-7299.2021.04.017.

4.高瞻, 李红武, 臧艳, 等. 348例突发性聋的发病季节规律性研究[J]. 安徽医科大学学报, 2021, 56(5): 806-809. [Gao Z, Li HW, Zang Y, et al. A study on the seasonal regularity of 348 cases of sudden deafness[J]. Journal of Anhui Medical University, 2021, 56(5): 806-809.] DOI: 10.19405/j.cnki.issn1000-1492.2021.05.025.

5.杨庆军, 宋玉美, 赵春杰, 等. 基于炎症标志物和临床特征特发性突发性感音神经性耳聋预后模型构建 [J].  医药论坛杂志, 2023, 44(24): 18-23. [Yang QJ, Song YM, Zhao CJ, et al. Construction of a prognostic model for idiopathic sudden sensorineural hearing loss based on inflammatory markers and clinical features[J]. Journal of Medical Forum, 2023, 44(24): 18-23.] https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202324004.htm.

6.Veldman JE. Cochlear and retrocochlear immune-mediated inner ear disorders. Pathogenetic mechanisms and diagnostic tools[J]. Ann Otol Rhinol Laryngol, 1986, 95(5Pt1): 535-540. DOI: 10.1177/000348948609500518.

7.张心怡, 张静. 巴曲酶治疗突发性耳聋引起眩晕合并血栓患者的疗效观察[J]. 血栓与止血学, 2021, 27(2): 264-265, 268. [Zhang XY, Zhang J. Observation of the therapeutic effect of batroxobin on patients with sudden deafness induced dizziness and thrombosis[J]. Thrombosis and Hemostasis, 2021, 27(2): 264-265, 268.] DOI: 10.3969/j.issn.1009-6213.2021.02.032.

8.李菁, 苏涛, 张舜, 等. 补阳还五汤联合巴曲酶对突发性耳聋患者中医证候、听力水平及血清ET-1、CysC、MMP-2的影响[J]. 广州中医药大学学报, 2023, 40(11): 2786-2791. [Li J, Su T, Zhang S, et al. The effect of Buyang Huanwu Tang combined with batroxobin on traditional Chinese medicine syndrome, hearing level, and serum ET-1, CysC, MMP-2in patients with sudden deafness[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2023, 40(11): 2786-2791.] DOI: 10.13359/j.cnki.gzxbtcm.2023.11.015.

9.朱合叶, 张坤, 陈广涛. 金纳多注射液联合巴曲酶注射液治疗突发性耳聋患者的效果观察[J]. 临床医学工程, 2023, 30(9): 1205-1206. [Zhu HY, Zhang K, Chen GT. Observation on the efficacy of Jinnado injection combined with batroxobin injection in the treatment of sudden deafness patients[J]. Clinical Medical Engineering, 2023, 30(9): 1205-1206.] DOI: 10.3969/j.issn.1674-4659.2023.09.1205.

10.姚琦, 潘晓峰, 潘宋斌, 等. 金纳多治疗良性阵发性位置性眩晕复位成功后残余头晕症状的疗效评估[J]. 中华耳科学杂志, 2020, 18(5): 897-901. [Yao Y, Pan XF, Pan SB, et al. Effect of ginkgo on residual dizziness after successful particle repositioning maneuver in benign paroxysmal positional vertigo[J]. Chinese Journal of Otology, 2020, 18(5): 897-901.] DOI: 10.3969/j.issn.1672-2922.2020.05.017.

11.中华医学会耳鼻咽喉头颈外科学分会, 中华耳鼻咽喉头颈外科杂志编辑委员会. 突发性耳聋诊断和治疗指南[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447. DOI: 10.3760/cma.j.issn.1673-0860.2015.06.002.

12.Islamoglu Y, Kesici GG, Ercan K, et al. Single-sided deafness after sudden hearıng loss: late effect on cochlear nerve size[J]. Eur Arch Otorhinolaryngol, 2020, 277(9): 2423-2426. DOI: 10.1007/s00405-020-05977-x.

13.雷杰, 毕梦, 杨飞, 等. 前列地尔联合地塞米松及高压氧治疗突发性耳聋伴眩晕的疗效评价[J]. 西部医学, 2018, 30(6): 892-895. [Lei J, Bi M, Yang F, et al. Clinical observation on alprostadil combined with hyperbaric oxygen and dexamethasone in the treatment of sudden deafness with vertigo[J]. Medical Journal of West China, 2018, 30(6): 892-895.] DOI: 10.3969/j.issn.1672-3511.2018.06.027.

14.Wang YH, Huang JR, Qian GZ, et al. Study on the correlation between different levels of patients with vertebrobasilar dolichoectasia and posterior circulation blood perfusion[J]. J Stroke Cerebrovasc Dis, 2022, 31(5): 106378. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106378.

15.施陈燕, 李昕, 张治军, 等. 中药治疗眩晕的作用机制及主要靶点[J]. 中国中西医结合耳鼻咽喉科杂志, 2023, 31(6): 467-471, 477. [Shi CY, Li X, Zhang ZJ, et al. The mechanism and main targets of traditional Chinese medicine in treating dizziness[J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine in Otolaryngology, 2023, 31(6): 467-471, 477.] DOI: 10.16542/j.cnki.issn.1007-4856.2023.06.016.

16.何玲, 王宁. 巴曲酶治疗全频下降突发性聋的临床疗效分析[J]. 湖南师范大学学报(医学版), 2022, 19(5): 55-58. [He L, Wang N. Clinical efficacy of batroxobinor in treatment of all frequency desceding sudden deafness[J]. Journal of Hunan Normal University (Medical Science), 2022, 19(5): 55-58.] DOI: 10.3969/j.issn.1673-016X.2022.05.013.

17.张冀琳, 汪艳. 巴曲酶联合地塞米松治疗突发性耳聋患者疗效及对凝血指标的影响[J]. 血栓与止血学, 2022, 28(3): 970-971. [Zhang JL, Wang Y. Effect of batroxobin combined with dexamethasone in the treatment of sudden deafness and its effect on coagulation indexes[J]. Chinese Journal of Thrombosis and Hemostasis, 2022, 28(3): 970-971.] DOI: 10.3969/j.issn.1009-6213.2022.03.278.

18.林远超, 刘义平. 耳后注射地塞米松联合银杏叶提取物注射液静脉滴注治疗突发性耳聋的疗效观察[J]. 实用临床医药杂志, 2023, 27(8): 109-112. [Lin YC, Liu YP. Observation on the therapeutic effect of intravenous infusion of dexamethasone combined with ginkgo biloba extract injection after ear injury in the treatment of sudden deafness[J]. Journal of Practical Clinical Medicine, 2023, 27(8): 109-112.] DOI: 10.7619/jcmp.20223850.

19.朱丽平, 谭晓晔, 蒯烨滨, 等. 金纳多注射液联合地塞米松治疗突发性耳聋的效果及对血清ET、sVCAM-1、AECA水平的影响[J]. 中国医药导报, 2022, 19(6): 106-109. [Zhu LP, Tan XH, Kuai YB, et al. Effect of gennadol injection combined with dexamethasone in the treatment of sudden deafness and its effect on serum ET, sVCAM-1 and AE-CA levels[J]. China Medical Herald, 2022, 19(6):106-109.] https://d.wanfangdata.com.cn/periodical/yycyzx202206025.

20.张炜, 贾国章, 杨斌,等. 突发性耳聋患者免疫及血清炎性因子变化及临床意义研究[J]. 临床误诊误治, 2019, 32(7): 77-80. [Zhang W, Jia GZ, Yang B, et al. Changes of immune and serum inflammatory factor levels in patients with sudden deafness and their clinical significance[J]. Clinical Misdiagnosis & Mistherapy, 2019, 32(7): 77-80.] DOI: 10.3969/j.issn.1002-3429.2019.07.019.

21.李明, 姚文平, 黄谦, 等. 桂枝加葛根汤结合温针灸对颈性眩晕患者IL-6、hs-CRP、ET-1及NO的影响 [J]. 中华针灸电子杂志, 2023, 12(3): 95-100. [Li M, Yao WP, Huang Q, et al. Effects of Guizhi Jiagegen Decoction combined with warm acupuncture and moxibustion on IL-6, hs CRP, ET-1and NO in patients with cervical vertigo[J]. Chinese Electronic Journal of acupuncture and moxibustion, 2023, 12(3): 95-100.] DOI: 10.3877/cma.j. issn.2095-3240.2023.03.003.

22.孙方纬. 巴曲酶治疗超早期急性脑梗死的疗效评价[J]. 北华大学学报(自然科学版), 2008, 9(4): 338-340. [Sun FW. Evaluation of the therapeutic effect of batroxobin in the treatment of ultra early acute cerebral infarction[J]. Journal of Beihua University (Natural Science Edition), 2008, 9(4): 338-340.] DOI: 10.3969/j.issn.1009-4822.2008.04.012.

23.陈剑靖, 徐美丽, 何子夜, 等. 银杏叶提取物金纳多对敌草快诱导大鼠急性肾损伤的改善作用[J]. 山东医药, 2023, 63(18): 49-53. [Chen JJ, Xu ML, He ZY, et al. Ameliorative effect of Ginkgo biloba extract Ginaton on diquat-induced acute kidney injury in rats[J]. Shandong Pharmaceutical, 2023, 63(18): 49-53.] DOI: 10.3969/j. issn.1002-266X.2023.18.011.